Hinge Health (NYSE:HNGE) Cut to Hold at Wall Street Zen
Hinge Health (NYSE:HNGE-Get Free Report)was downgraded by research analysts atWall Street Zenfrom a "buy" rating to a "hold" rating in a research note issued on Saturday. MarketBeat Week in Review – 02/23 -. . .
Hinge Health (NYSE:HNGE-Get Free Report)was downgraded by research analysts atWall Street Zenfrom a "buy" rating to a "hold" rating in a research note issued on Saturday. MarketBeat Week in Review – 02/23 - 02/27HNGE has been the topic of a number of other research reports. Weiss Ratingsreissued a "sell (d-)" rating on shares of Hinge Health in a research report on Monday. Evercore reiterated an "outperform" rating and set a $105. 00 price objective on shares of Hinge Health in a research note on Wednesday. Canaccord Genuity Group set a $105. 00 price objective on shares of Hinge Health in a report on Wednesday. Citigroup restated an "outperform" rating on shares of Hinge Health in a report on Monday, July 27th. Finally, Wells Fargo & Company increased their target price on Hinge Health from $90. 00 to $103. 00 and gave the company an "overweight" rating in a research report on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $98. 64. GetHinge Healthalerts:Get Our Latest Stock Analysis on Hinge HealthHinge Health Stock Up 11. 2%Hinge Health’s AI Moat Might Be Its Patient Movement DataShares ofNYSE:HNGEopened at $89. 04 on Friday. The business's 50 day moving average is $76. 22 and its 200 day moving average is $54. 93. The stock has a market cap of $6. 89 billion, a P/E ratio of 69. 56 and a beta of 1. 30. Hinge Health has a 52-week low of $30. 08 and a 52-week high of $91. 50. Hinge Health (NYSE:HNGE-Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported $0. 59 earnings per share for the quarter, beating analysts' consensus estimates of $0. 28 by $0. 31. Hinge Health had a return on equity of 65. 44% and a net margin of 15. 15%. The business had revenue of $212. 82 million during the quarter. During the same period last year, the firm earned $0. 59 earnings per share. The company's revenue for the quarter was up 53. 0% on a year-over-year basis. On average, sell-side analysts anticipate that Hinge Health will post 1. 37 EPS for the current fiscal year. Insiders Place Their BetsNotable Newcomers: These 2025 IPOs Dominated the YearIn other news, ChairmanGabriel M. I. Mecklenburgsold 83,334 shares of the business's stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $85. 05, for a total transaction of $7,087,556. 70. Following the sale, the chairman owned 83,334 shares in the company, valued at approximately $7,087,556. 70. The trade was a 50. 00% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible throughthis hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, PresidentJames Pursleysold 33,000 shares of the company's stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $69. 31, for a total transaction of $2,287,230. 00. Following the transaction, the president owned 740,897 shares in the company, valued at approximately $51,351,571. 07. This trade represents a 4. 26% decrease in their position. TheSEC filingfor this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 3,721,100 shares of company stock valued at $288,210,699. 18. 92% of the stock is currently owned by corporate insiders. Institutional Inflows and OutflowsHedge funds and other institutional investors have recently made changes to their positions in the stock. Marshall Wace LLP purchased a new stake in shares of Hinge Health during the second quarter valued at $367,000. Sei Investments Co. purchased a new position in Hinge Health in the 2nd quarter worth $869,000. Squarepoint Ops LLC purchased a new position in Hinge Health in the 2nd quarter worth $19,706,000. Raymond James Financial Inc. acquired a new stake in Hinge Health during the 2nd quarter worth about $3,258,000. Finally, Sandia Investment Management LP purchased a new stake in Hinge Health during the 2nd quarter valued at about $657,000. Hinge Health Company Profile(Get Free Report)Hinge HealthNYSE: HNGEis a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions. Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs. Further ReadingFive stocks we like better than Hinge HealthDatadog’s Drop Says More About Expectations Than EarningsD-Wave's Quantum Breakthrough Couldn't Save QBTS From a Sell-OffCloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in FocusSolventum Nears Inflection Point As It Begins to Unlock ValueThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Continue following MarketBeatAdd MarketBeat as your preferred source on Google to see our latest stories in your feed. Should You Invest $1,000 in Hinge Health Right Now?Before you consider Hinge Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Hinge Health wasn't on the list. While Hinge Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report